H Michael Cohen Net Worth

The estimated Net Worth of H Michael Cohen is at least $831 Thousand dollars as of 26 May 2023. Mr. Cohen owns over 1,435 units of Masimo Corp stock worth over $436,548 and over the last 5 years he sold MASI stock worth over $132,292. In addition, he makes $262,387 as Independent Director at Masimo Corp.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Cohen MASI stock SEC Form 4 insiders trading

H has made over 4 trades of the Masimo Corp stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 1,435 units of MASI stock worth $163,863 on 26 May 2023.

The largest trade he's ever made was exercising 1,435 units of Masimo Corp stock on 26 May 2023 worth over $163,863. On average, H trades about 815 units every 218 days since 2019. As of 26 May 2023 he still owns at least 3,823 units of Masimo Corp stock.

You can see the complete history of Mr. Cohen stock trades at the bottom of the page.

H Michael Cohen biography

H Michael Cohen serves as Independent Director of the Company. He has almost 30 years of experience in the healthcare industry. Over the past 19 years, he has held various roles at Deutsche Bank, including Global Head, Healthcare Investment Banking and most recently Vice Chairman, Healthcare Investment Banking. Prior to joining Deutsche Bank, Mr. Cohen worked at SG Cohen, Union Bank of Switzerland, and Booz Allen Hamilton. Mr. Cohen began his career in healthcare at Hambrecht & Quist, where he was a member of the equity research team covering biotechnology, medical device and diagnostic companies. He received his B.A. in Economics from the University of Vermont and his M.B.A. from Columbia University.

What is the salary of H Cohen?

As the Independent Director of Masimo Corp, the total compensation of H Cohen at Masimo Corp is $262,387. There are 17 executives at Masimo Corp getting paid more, with Joseph Kiani having the highest compensation of $14,996,100.

How old is H Cohen?

H Cohen is 54, he's been the Independent Director of Masimo Corp since 2018. There are 14 older and 11 younger executives at Masimo Corp. The oldest executive at Masimo Corp is Thomas Harkin, 80, who is the Independent Director.

What's H Cohen's mailing address?

H's mailing address filed with the SEC is C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE, CA, 92618.

Insiders trading at Masimo Corp

Over the last 17 years, insiders at Masimo Corp have traded over $198,004,099 worth of Masimo Corp stock and bought 212,683 units worth $10,354,127 . The most active insiders traders include Joe E Kiani, Edward L Cahill, and Yongsam Lee. On average, Masimo Corp executives and independent directors trade stock every 14 days with the average trade being worth of $2,669,077. The most recent stock trade was executed by Joe E Kiani on 8 August 2024, trading 231,748 units of MASI stock currently worth $8,769,344.

What does Masimo Corp do?

masimo (nasdaq: masi) is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, including medical devices and a wide array of sensors. our work is making a measurable difference in the world by saving, extending and improving the lives of people of all ages, in all walks of life for more than 27 years, our innovative medical technologies and noninvasive patient monitoring solutions have been solving ‘unsolvable’ problems. the result is a portfolio of clinically-proven products that lead the way in innovation, performance and patient safety by giving health care providers the information they need to optimize clinical decision-making. masimo is for‘what-ifers’, ‘never-say-never-ers’, and ‘world changers’—people who look beyond what others see. we're looking for people who can, do, and will make a difference. we think you'll like what you see.

Complete history of Mr. Cohen stock trades at Masimo Corp

Masimo Corp executives and stock owners

Masimo Corp executives and other stock owners filed with the SEC include:

• Joseph Kiani,
  Chairman of the Board, Chief Executive Officer
• Bilal Muhsin,
  Chief Operating Officer
• Joseph E. Kiani,
  Founder, CEO & Chairman
• Tao Levy,
  Executive Vice President - Business Development
• Anand Sampath,
  Executive Vice President - Operations & Clinical Research
• Tom McClenahan,
  Executive Vice President, General Counsel, Corporate Secretary
• Micah Young,
  Chief Financial Officer, Executive Vice President
• Jon Coleman,
  President - Worldwide Sales, Professional Services and Medical Affairs
• Yongsam Lee,
  Executive Vice President, Chief Information Officer
• Bilal Muhsin,
  Chief Operating Officer
• Micah Young,
  Exec. VP of Fin. & CFO
• Thomas Samuel McClenahan,
  Exec. VP, Gen. Counsel & Corp. Sec.
• Tao Leopold Levy,
  Exec. VP of Bus. Devel.
• Adam Mikkelson,
  Independent Director
• Craig Reynolds,
  Independent Director
• Thomas Harkin,
  Independent Director
• Sanford Fitch,
  Independent Director
• H Michael Cohen,
  Independent Director
• Julie Shimer,
  Independent Director
• Steven Barker,
  Director
• Dr. Steven J. Barker,
  Chairman of Scientific Advisory Board & Chief Science Officer
• Eli Kammerman,
  Investor Relations Officer
• J. Todd Koning,
  Chief Accounting Officer
• Jon Coleman,
  Pres of Worldwide Sales, Professional Services & Medical Affairs
• Yongsam Lee,
  Exec. VP & Chief Information Officer
• Thierry Leclercq,
  Exec. VP of Bus. Devel.
• Anand Sampath,
  Exec. VP of Operations & Clinical Research
• Joe E Kiani,
  CEO and Chairman of the Board
• Raad Mark De,
  EVP & Chief Financial Officer
• Thierry Leclercq,
  EVP, Bus Dev
• Paul Jansen,
  Executive VP, Marketing
• Thomas Samuel Mc Clenahan,
  EVP, GEN COUNSEL & CORP SEC
• Michelle Brennan,
  Director
• Blair Tripodi,
  COO, Consumer Division
• Christopher Kilpatrick,
  EVP, Business Dev., GC & Sec.
• Olivier Berthon,
  President, Masimo Europe
• Michael O'reilly,
  EVP, Medical Affairs
• Ammar Al Ali,
  Chief Technical Officer
• David Goodman,
  EVP, Business Development
• Stephen M Moran,
  EVP, General Counsel
• Stephen E. Paul,
  Vice President, US Acute Care
• Rick Fishel,
  President of Masimo Americas
• Robert Coleman,
  Director
• Brian Campbell,
  
• Mohamed Elmandjra,
  Pres., Worldwide OEM Business
• Edward L Cahill,
  Director
• Jack W Lasersohn,
  Director
• Anthony Allan,
  Chief Operating Officer
• Robert A Chapek,
  Director
• Ramshorst David J Van,
  SVP, Chief Accounting Officer
• Kevin P Duffy,
  President, Consumer
• Capital Management Lp Polit...,
  
• Rolf A Classon,
  Director